Molecule to cure. Fast.
Solutions
Quotient Sciences' drug discovery and turnkey drug development solutions are designed to unlock all the available opportunities for our partnering customers. Fast.
Unlock your small molecule's drug development opportunities by partnering with Quotient Sciences, a proactive collaborator with a vision to deliver an exceptional experience to our customers and set new standards of collaboration for the pharmaceutical industry, with scientific expertise and partnership at its core.
Translational Pharmaceutics®
Quotient Sciences’ Translational Pharmaceutics® platform innovates the way you design and implement your drug development program. It offers you integrated formulation development, real-time adaptive GMP manufacturing and clinical research capabilities proven to reduce drug development costs and shorten timelines. Translational Pharmaceutics® transforms the traditional approach of outsourcing development work to separate contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) – simplifying and streamlining your outsourcing and program management.
Pediatrics
The development of acceptable, palatable pediatric formulations is a key feature within the industry today, driven by patient needs and regulatory requirements.
Quotient Sciences has extensive knowledge and capabilities that enable us to provide you with a unique integrated development solution.
Oncology
If you are looking to accelerate the development of your oncology drug candidate, we are your ideal partner. At Quotient Sciences we have worked on over 300 oncology development projects for 91 different oncology drug candidates spanning 34 different disease indications. Our experts are ready to discuss your oncology drug development today.
Orphan Rare Diseases
Throughout the world, there are over 300 million people living with identified rare diseases. At Quotient Sciences we recognize that there is a clinical need to accelerate orphan drug development from candidate selection to commercial manufacture and supply. In the past five years, we have developed over 50 rare disease programs, we understand their barriers and possess the expertise needed to get these programs to patients fast.
Inhaled Drug Development
Quotient Sciences have many years of experience across a range of inhalation drug delivery platforms including dry powder inhalers (DPIs) and solutions and suspensions for inhalation.
Trust our scientific experts
In whichever therapeutic area or disease indication you are developing, you can trust Quotient Sciences' extensive expertise and open-minded, innovative scientists to get your pharmaceutical drug product to the people who need it most. Fast.